Literature DB >> 15930728

Antihypertensive potential and mechanism of action of astaxanthin: II. Vascular reactivity and hemorheology in spontaneously hypertensive rats.

Ghazi Hussein1, Hirozo Goto, Shinobu Oda, Tomomi Iguchi, Ushio Sankawa, Kinzo Matsumoto, Hiroshi Watanabe.   

Abstract

The current study was designed to determine the effects of a dietary astaxanthin (ASX-O) on vascular reactivity in spontaneously hypertensive rats (SHR), in order to verify its antihypertensive action mechanism. We evaluated contractions induced by phenylephrine (Phe), angiotensin II (Ang II) and the xanthine/xanthine oxidase (Xan/XOD) system, and relaxations induced by sodium nitroprusside (SNP) as well as endothelium-dependent relaxations mediated by acetylcholine (ACh) in thoracic aorta of the SHR, with and without ASX-O intervention. We also investigated the effects of ASX-O on blood rheology using a microchannel array system. In this study, ASX-O showed a significant modulatory effect on nitric oxide (NO)-induced vasorelaxation by the NO-donor SNP (p<0.05). However, it did not show significant effects in restoring the impaired endothelium-dependent relaxation to ACh in the SHR. On the other hand, the constrictive effects by Phe, Ang II and Xan/XOD were ameliorated by ASX-O (p<0.05). ASX-O also demonstrated significant hemorheological effect by decreasing the microchannel transit time of whole blood. In conclusion, the results suggest that ASX-O may act in modulating the blood fluidity in hypertension, and that the antihypertensive effects of ASX-O may be exerted through mechanisms including normalization of the sensitivity of the adrenoceptor sympathetic pathway, particularly [alpha]-adrenoceptors, and by restoration of the vascular tone through attenuation of the Ang II- and reactive oxygen species (ROS)-induced vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930728     DOI: 10.1248/bpb.28.967

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Astaxanthin increases choroidal blood flow velocity.

Authors:  Michiyuki Saito; Kazuhiko Yoshida; Wataru Saito; Akio Fujiya; Kazuhiro Ohgami; Nobuyoshi Kitaichi; Hiroki Tsukahara; Susumu Ishida; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-10       Impact factor: 3.117

2.  Antihypertensive effects of astaxanthin.

Authors:  Hidekatsu Yanai; Kumie Ito; Hiroshi Yoshida; Norio Tada
Journal:  Integr Blood Press Control       Date:  2008-10-27

Review 3.  Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications.

Authors:  Rebecca Landon; Virginie Gueguen; Hervé Petite; Didier Letourneur; Graciela Pavon-Djavid; Fani Anagnostou
Journal:  Mar Drugs       Date:  2020-07-09       Impact factor: 5.118

4.  Effects of Dietary Supplementation with Astaxanthin on Histamine Induced Lesions in the Gizzard and Proventriculus of Broiler Chicks.

Authors:  Mi-Hyang Ohh; Seongjin Kim; Sok Cheon Pak; Kew-Mahn Chee
Journal:  Asian-Australas J Anim Sci       Date:  2016-01-29       Impact factor: 2.509

5.  H2O2 Induces Association of RCA with the Thylakoid Membrane to Enhance Resistance of Oryza meyeriana to Xanthomonas oryzae pv. oryzae.

Authors:  Qiong Mei; Yong Yang; Shenhai Ye; Weifang Liang; Xuming Wang; Jie Zhou; Chulang Yu; Chengqi Yan; Jianping Chen
Journal:  Plants (Basel)       Date:  2019-09-16

6.  Astaxanthin Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Oxidative Stress-Induced Mitochondrial Dysfunction.

Authors:  Yuqiong Chen; Su Li; Yuxuan Guo; Hang Yu; Yandong Bao; Xin Xin; Huimin Yang; Xinzhu Ni; Nan Wu; Dalin Jia
Journal:  Oxid Med Cell Longev       Date:  2020-04-14       Impact factor: 6.543

Review 7.  Astaxanthin as a Modulator of Nrf2, NF-κB, and Their Crosstalk: Molecular Mechanisms and Possible Clinical Applications.

Authors:  Sergio Davinelli; Luciano Saso; Floriana D'Angeli; Vittorio Calabrese; Mariano Intrieri; Giovanni Scapagnini
Journal:  Molecules       Date:  2022-01-14       Impact factor: 4.411

Review 8.  Astaxanthin from Crustaceans and Their Byproducts: A Bioactive Metabolite Candidate for Therapeutic Application.

Authors:  Vida Šimat; Nikheel Bhojraj Rathod; Martina Čagalj; Imen Hamed; Ivana Generalić Mekinić
Journal:  Mar Drugs       Date:  2022-03-12       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.